Hyperfine stock gained 2.54 percent after Gulf distributor deal

Published on 10/05/2026 at 09:49 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Hyperfine stock posted USD 3.9 million in Q2 revenue, up 44.8 percent year over year on June 30, 2026. Five analysts rate it Hold.

HYPR, US44916K1060, Illustration mit AI erstellt.

Hyperfine stock (ISIN US44916K1060) gained 2.54 percent to USD 0.8938 on Nasdaq on October 2, 2026, as the portable MRI company expanded its international distribution footprint. On September 28, Hyperfine appointed Roots Pharmaceutical as the exclusive Swoop distributor for Kuwait and the United Arab Emirates, according to Hyperfine.

Gulf deal broadens Swoop reach

Roots will handle market development, local regulatory work, product education, demonstrations and customer engagement in both countries. Commercial and service activities depend on the applicable regulatory clearances, giving the agreement a market-access angle rather than an immediate revenue commitment.

The deal adds two Gulf markets to Hyperfine's international distribution strategy for Swoop, its FDA-cleared portable, ultra-low-field brain MRI system. The company says the system is designed for imaging at multiple points of care, including hospitals, emergency departments and neurology offices.

Revenue grows while losses remain high

Hyperfine reported USD 3.904 million of revenue for the quarter ended June 30, 2026, compared with USD 2.7 million a year earlier, a 44.8 percent increase, according to StockTitan. The same quarter produced a net loss of USD 9.298 million and diluted EPS of negative USD 0.09.

The growth rate is meaningful, but the loss shows the commercial hurdle still facing the business. Management's 2026 revenue guidance is USD 20 million to USD 22 million, while the company expects cash burn of USD 26 million to USD 28 million, figures reported with the second-quarter filing by StockTitan.

Analysts see a wider valuation gap

MarketBeat reports a consensus Hold rating from five covering brokerages, with three Buy ratings, one Hold and one Sell. The average 12-month price target is USD 2.03, placing the target 127.5 percent above the October 2 Nasdaq price of USD 0.8938, according to MarketBeat. The spread reflects a market weighing revenue growth against sustained losses and funding needs.

Nasdaq compliance adds a risk marker

Hyperfine received a Nasdaq notice on September 17, 2026 after its Class A shares traded below the USD 1.00 minimum bid requirement for 30 consecutive business days. The company has until March 16, 2027 to regain compliance, according to StockTitan.

HYPR stays below its yearly high

HYPR's October 2 Nasdaq closing price was USD 0.8938, with volume of 1,403,954 shares and a 52-week range of USD 0.7540 to USD 2.2200. Market capitalization stood at USD 94.8 million on the same date, while the next earnings date is November 12, 2026.